LIMINAL BIOSCIENCES INC (LMNL) Forecast, Price Target & Analyst Ratings

NASDAQ:LMNL • CA53272L2021

Current stock price

8.5 USD
+0.01 (+0.12%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LIMINAL BIOSCIENCES INC (LMNL).

Forecast Snapshot

Consensus Price Target

Price Target
$7.65
-10.00% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 7, 2023
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.65
Upside
-10.00%
From current price of $8.50 to mean target of $7.65, Based on 6 analyst forecasts
Low
$7.58
Median
$7.65
High
$7.88

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for LMNL. The average price target is 7.65 USD. This implies a price decrease of -10% is expected in the next year compared to the current price of 8.5.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LMNL Current Analyst RatingLMNL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

LMNL Historical Analyst RatingsLMNL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
LMNL was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about LMNL.
In the previous month the buy percentage consensus was at a similar level.
LMNL was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-06-24HC Wainwright & Co.Downgrade Buy -> Neutral
2021-06-02Piper SandlerDowngrade Overweight -> Neutral
2021-02-18HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 7, 2023

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2024

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024
Revenue
YoY % growth
LMNL revenue by date.LMNL revenue by date.
3.32M
-32.24%		643K
-80.63%		401K
-37.64%
-100.00%
EBITDA
YoY % growth
LMNL ebitda by date.LMNL ebitda by date.
-85.64M
20.96%		-46.335M
45.90%		-31.792M
31.39%		N/AN/A
EBIT
YoY % growth
LMNL ebit by date.LMNL ebit by date.
-94.09M
20.44%		-50.679M
46.14%		-32.912M
35.06%		N/AN/A
Operating Margin
LMNL operating margin by date.LMNL operating margin by date.
-2,834.04%-7,881.65%-8,207.48%N/AN/A
EPS
YoY % growth
LMNL eps by date.LMNL eps by date.
N/A12.92
134.63%		N/A
-108.68%		-11.30
-907.27%		-12.29
-8.75%

All data in CAD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LMNL Yearly Revenue VS EstimatesLMNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
LMNL Yearly EPS VS EstimatesLMNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 0 10 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LIMINAL BIOSCIENCES INC / LMNL Forecast FAQ

What is the average price target for LIMINAL BIOSCIENCES INC (LMNL) stock?

6 analysts have analysed LMNL and the average price target is 7.65 USD. This implies a price decrease of -10% is expected in the next year compared to the current price of 8.5.

What is the next earnings date for LMNL stock?

LIMINAL BIOSCIENCES INC (LMNL) will report earnings on 2023-11-07, after the market close.

What is the consensus rating for LMNL stock?

The consensus rating for LIMINAL BIOSCIENCES INC (LMNL) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.